In hepatocellular carcinoma, activation of the AKT/mTOR signaling pathway promotes tumor cell clonability and survival potential and metabolic alterations, leading to poor prognosis [42, 43]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.